TOT Biopharm: Profit Alert from Significant CDMO Achievement

EQS Newswire / 27/05/2024 / 22:00 UTC+8
TOT Biopharm (1875.HK) has reached a new milestone in its performance. On May 10th, the company announced its 24Q1 financial results, with operating revenue

Related Keywords

China , Egypt , Indonesia , Suzhou , Jiangsu , United States , Egyptian , Chinese , Indonesian , , Egyptian Drug Authority , European Union , Drug Authority , Financial Press , Indonesian Food , Suzhou City , Jiangsu Province , Financial Press Release , Ihr Portfolio ,